S'abonner

Evaluation of metagenomic and pathogen-targeted next-generation sequencing for diagnosis of meningitis and encephalitis in adults: A multicenter prospective observational cohort study in China - 30/04/24

Doi : 10.1016/j.jinf.2024.106143 
Weibi Chen a, Gang Liu a, Lili Cui a, Fei Tian a, Jiatang Zhang b, Jiahua Zhao b, Ying Lv c, Jianxin Du a, d, Xinyu Huan d, Yingfeng Wu e, , Yan Zhang a, f,
a Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China 
b Department of Neurology, the First Medical Center of People's Liberation Army General Hospital, Beijing, China 
c Department of Neurology & Psychiatry, Beijing Shijitan Hospital, Capital Medical University, Beijing, China 
d Department of Neurosurgery, Beijing Fengtai Youanmen Hospital, Beijing, China 
e Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China 
f Department of Sleep and Consciousness Disorders, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, China 

Correspondence to: Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, No.45 Changchun Street, Xicheng District, Beijing 100053, China.Department of Vascular Surgery, Xuanwu Hospital, Capital Medical UniversityNo.45 Changchun Street, Xicheng DistrictBeijing100053China⁎⁎Correspondence to: Department of Neurology, Xuanwu Hospital, Capital Medical University, No.45 Changchun Street, Xicheng District, Beijing 100053, China.Department of Neurology, Xuanwu Hospital, Capital Medical UniversityNo.45 Changchun Street, Xicheng DistrictBeijing100053China.

Summary

Background

Next-generation sequencing (NGS) might aid in the identification of causal pathogens. However, the optimal approaches applied to cerebrospinal fluid (CSF) for detection are unclear, and studies evaluating the application of different NGS workflows for the diagnosis of intracranial infections are limited.

Methods

In this multicenter, prospective observational cohort study, we described the diagnostic efficacy of pathogen-targeted NGS (ptNGS) and metagenomic NGS (mNGS) compared to that of composite microbiologic assays, for infectious meningitis/encephalitis (M/E).

Results

In total, 152 patients diagnosed with clinically suspected M/E at four tertiary hospitals were enrolled; ptNGS and mNGS were used in parallel for pathogen detection in CSF. Among the 89 patients who were diagnosed with definite infectious M/E, 57 and 39 patients had causal microbial detection via ptNGS and mNGS, respectively. The overall accuracy of ptNGS was 65.1%, with a positive percent agreement (PPA) of 64% and a negative percent agreement (NPA) of 66.7%; and the overall accuracy of mNGS was 47.4%, with a PPA of 43.8% and an NPA of 52.4% after discrepancy analysis. There was a significant difference in the detection efficiency between these two methods both for PPA (sensitivity) and overall accuracy for pathogen detection (P < 0.05).

Conclusions

NGS tests have provided new information in addition to conventional microbiologic tests. ptNGS seems to have superior performance over mNGS for common causative pathogen detection in CSF for infectious M/E.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




ga1

Le texte complet de cet article est disponible en PDF.

Highlights

Detection efficiencies of ptNGS for pathogen detection in CSF were higher than mNGS.
False positive rate of ptNGS for infectious M/E was lower than mNGS.
ptNGS had superior performance over mNGS in CSF for the common pathogen.
ptNGS had more potential than mNGS in detecting target viruses in CSF

Le texte complet de cet article est disponible en PDF.

Keywords : Encephalitis, Metagenomic next-generation sequencing, Pathogen-targeted next-generation sequencing, Cerebrospinal fluid


Plan


© 2024  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 88 - N° 5

Article 106143- mai 2024 Retour au numéro
Article précédent Article précédent
  • Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study
  • Saverio Caini, Jean-Sebastien Casalegno, Ana Paula Rodrigues, Vernon Lee, Cheryl Cohen, Q.Sue Huang, Alfredo Bruno Caicedo, Anne Teirlinck, Raquel Guiomar, Li Wei Ang, Jocelyn Moyes, Tim Wood, Doménica de Mora, Mathieu Bangert, VRS Study Group in Lyon, Rolf Kramer, Lisa Staadegaard, Susanne Heemskerk, Jojanneke van Summeren, Adam Meijer, John Paget
| Article suivant Article suivant
  • Risk of death in Klebsiella pneumoniae bloodstream infections is associated with specific phylogenetic lineages
  • Aasmund Fostervold, Niclas Raffelsberger, Marit A.K. Hetland, Ragna Bakksjø, Eva Bernhoff, Ørjan Samuelsen, Arnfinn Sundsfjord, Jan E. Afset, Christopher F. Berntsen, Roar Bævre-Jensen, Marit H. Ebbesen, Karianne W. Gammelsrud, Anja D. Guleng, Nina Handal, Aleksandra Jakovljev, Simreen K. Johal, Åshild Marvik, Ane Natvik, Rolf-Arne Sandnes, Ståle Tofteland, Jørgen V. Bjørnholt, Iren H. Löhr, Assoc. on behalf of The Norwegian Study Group on Klebsiella pneumoniae

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.